Clinical Trials Logo

Nerve Injury clinical trials

View clinical trials related to Nerve Injury.

Filter by:

NCT ID: NCT06185426 Active, not recruiting - Nerve Injury Clinical Trials

Histopathological, Biochemical And Electrophysiological Evaluation Of Single Or Combined Use Of Diode Laser/Steroid Treatment On Facial Nerve Injury

facial nerve
Start date: January 1, 2021
Phase: Early Phase 1
Study type: Interventional

The objective of the study will be to investigate the effect of low-level diode laser therapy (LLLT) and steroid on facial nerve injury. Thirty five male Wistar rat will randomly be divided into five groups: healthy control (HCG); damage control (DC); laser (LG); steroid (SG); and combined laser and steroid group (LSG). Right facial nerve electromyography (EMG) data will record after facial nerve damage done and before sacrification at 4th week.The results will be evaluated histopathologically, electrophysiologically and biochemically.

NCT ID: NCT06021262 Recruiting - Neurotoxicity Clinical Trials

Assessment of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity

Start date: August 2023
Phase:
Study type: Observational

The aim of this observational study is to answer the following questions in individuals with acute and chronic exposure to organophosphates. The main questions to be addressed are 1. What are the prognostic values of neuroinflammatory markers? 2. What are the genotoxic effects of organophosphates? 3. what are the changes occurring in the levels of traditional oxidative stress and inflammatory markers?

NCT ID: NCT05884125 Recruiting - Nerve Injury Clinical Trials

Promoting Healing of Injured Nerves With Electrical Stimulation Therapy

PHINEST
Start date: June 12, 2023
Phase: N/A
Study type: Interventional

This study is evaluating a new therapeutic use of electrical stimulation to promote nerve healing and improve functional recovery following surgical intervention for peripheral nerve injury in arm. Participants will be randomized into one of two groups, treatment or control, with all participants receiving standard of care treatment for the nerve injury. The treatment group will also receive a single dose of the therapeutic stimulation during the surgical intervention for their nerve injury.

NCT ID: NCT05721261 Recruiting - Nerve Injury Clinical Trials

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

REGAIN
Start date: August 11, 2023
Phase: N/A
Study type: Interventional

A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.

NCT ID: NCT05611983 Recruiting - Nerve Injury Clinical Trials

Experience and Feasibility of Methods for Early Sensory Training

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The good effects of using guided plasticity for a rehabilitative purpose in case of nerve damage have been shown, but a problem that has been presented is that some individuals find it difficult to assimilate these effects due to difficulties in carrying out abstract training or due to a lack of motivation. In early sensory training, the plasticity of the brain is used. Methods for early sensory training that have been described are: 1) mental imagery of touch (mental imagery), 2) observation of touch, 3) mirror training, 4) use of images for visualization of touch. The method needs to be developed and refined to be able to offer individual training plans in order to find a motivating and meaningful form of training.

NCT ID: NCT05593237 Recruiting - Pain, Postoperative Clinical Trials

Transcranial Magnetic Stimulation for Chronic Neuropathic Pain

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

Chronic neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory nervous system. It is highly prevalent, debilitating, and challenging to treat. Current available treatments have low efficacy, high side effect burden, and are prone to misuse and dependence. Emerging evidence suggests that the transition from acute to chronic neuropathic pain is associated with reorganization of central brain circuits involved in pain processing. Repetitive transcranial magnetic stimulation (rTMS) is a promising alternative treatment that uses focused magnetic pulses to non-invasively modulate brain activity, a strategy that can potentially circumvent the adverse effects of available treatments for pain. RTMS is FDA-approved for the treatment of major depressive disorder, obsessive-compulsive disorder, and migraine, and has been shown to reduce pain scores when applied to the contralateral motor cortex (M1). However, available studies of rTMS for chronic neuropathic pain typically show variable and often short-lived benefits, and many aspects of optimal treatment remain unknown, including ideal rTMS stimulation parameters, duration of treatment, and relationship to the underlying pain etiology. Here the investigators propose to evaluate the efficacy of high frequency rTMS to M1, the region with most evidence of benefit in chronic neuropathic pain, and to use functional magnetic resonance imaging (fMRI) to identify alternative rTMS targets for participants that do not respond to stimulation at M1. The central aim is to evaluate the pain relieving efficacy of multi-session high-frequency M1 TMS for pain. In secondary exploratory analyses, the investigator propose to investigate patient characteristic that are predictive of responsive to M1 rTMS and identify viable alternative stimulation targets in non-responders to M1 rTMS.

NCT ID: NCT05589324 Completed - Nerve Injury Clinical Trials

Effects of 3D Printing Writing Assisitive Device on Feasibility in Patients With Nerve Injury

Start date: November 1, 2022
Phase:
Study type: Observational

Injury to the central or peripheral nerves can lead to limited hand function and further affect the ability of writing. The use of assistive devices can assist writing performance. However, the habit of holding the pen and the ability of the individual case will affect the selection of aids and the efficiency of writing. The 3D printing aids can be individually designed and adjusted to different angles and types. There is no criterion for 3D printing aids decision, often using a case-by-case trial subjective way to confirm, matching takes more time. Aim: To compare the applicability and efficiency of different types of 3D-printed writing aids in nerve injury cases, and to explore which factors affect the choice of aids.

NCT ID: NCT05365282 Recruiting - Clinical trials for Carpal Tunnel Syndrome

Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study

ACCESS-IV
Start date: March 18, 2024
Phase:
Study type: Observational

Evaluation of potential nerve damage after radial CAG/PCI.

NCT ID: NCT05302141 Completed - Nerve Injury Clinical Trials

Effects of Assistive Device on ADL Function in Patients With Nerve Injury

Start date: March 21, 2022
Phase: N/A
Study type: Interventional

Our study is aimed to evaluate the effect of 3D printing assistive device on hand function for patients with neural injury.

NCT ID: NCT05242302 Completed - Surgery Clinical Trials

AIN Transfer for Cubital Tunnel Syndrome

Start date: January 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Ulnar nerve compressive injury due to cubital tunnel syndrome is very common. Because of the long distance to the target muscles in the hand, functional outcome in severe cases even with decompression surgery is often poor. Therefore, alternative treatment options are much needed. Recently, anterior interosseous nerve reverse end to side (RETS) transfer to the ulnar nerve above the wrist has gained popularity. However, whether a substantial portion of motor axons in the donor nerve are indeed capable of breaching the connective tissues in the ulnar nerve to reach the target muscles in the hand remains untested. To answer this crucial question, in this study the investigators plan to recruit 60 cubital tunnel syndrome patients with marked motor axonal loss who will undergo the RETS procedure. Motor unit number estimation will be done on the ulnar and anterior interosseous nerves at baseline and repeated at 3 and 6 months post operatively. Hand motor function and disability scores will also be tested at the same time points. Given the importance of this critical question and the potential utilities of distal nerve transfers, this should be a worthwhile effort.